miR (microRNA)-192 plays key roles in renal pathological and physiological responses, by repressing targets including Zeb1, Zeb2 and Wnk1. In the present study, we have assessed the regulation of miR-192 expression. We found that TGF-β1 (transforming growth factor β1) down-regulates miR-192 and miR-194, co-transcribed in the shared precursor pri-miR (primary miR transcript)-192/194. Luciferase reporter analysis showed constitutive promoter activity within nucleotides + 21 to − 223. We identified HNF (hepatocyte nuclear factor) and p53 binding sites within this region that were required for constitutive promoter activity, which was decreased by TGF-β1 through an Alk5-dependent mechanism. TGF-β1 treatment decreased HNF binding to the miR-194-2/192 promoter, whereas knockdown of HNF-1 inhibited mature miR-192 and miR-194 expression. miR-192, miR-194 and HNF expression were restricted to a defined subset of human tissues including kidney, small intestine, colon and liver. Our results from the present study identify co-ordinated regulation of miR-192 and miR-194, with binding of HNF and p53 transcription factors necessary for activation of transcription, and TGF-β1-mediated repression through decreased HNF binding to its cognate promoter element.
INTRODUCTION
miRs (microRNAs) are a type of short single-stranded RNA molecule that function as potent regulators of gene expression. They act predominantly by binding to recognition sites in the 3 -UTR (3 -untranslated region) of target genes, leading to translational repression and mRNA destabilization. Emerging evidence shows that miR expression patterns contribute significantly to the definition of cellular phenotype in the kidney and elsewhere [1] . miR-34a, miR-192, miR-194, miR-203 and miR-450 are expressed preferentially in the renal cortex, and so may be of particular relevance to renal cell biology [2, 3] .
Our recent study identified reduced miR-192 expression in renal biopsy specimens from patients with advanced diabetic nephropathy, and correlated low expression of miR-192 with tubulointerstitial fibrosis and with low estimated glomerular filtration rate [4] . In vitro, incubation of PTCs (proximal tubular cells) with TGF-β1 (transforming growth factor β1) decreased miR-192 expression. Overexpression of miR-192 suppressed expression of the E-box repressors Zeb1 and Zeb2, thereby opposing TGF-β1-mediated down-regulation of E-cadherin, a key early step in TGF-β1-mediated fibrogenesis in the kidney. Similarly, Wang et al. [5] found down-regulation of miR-192 by TGF-β1 in proximal tubular cells and in kidneys from diabetic apoE mice, and linked this to TGF-β1-mediated repression of E-cadherin. In contrast, Kato et al. [6] found that TGF-β1 increased miR-192 expression in mouse mesangial cells, and that repression of Zeb1/2 expression by miR-192 facilitated collagen synthesis, enhancing matrix deposition and glomerulosclerosis. Kato et al. [7, 8] also identified additional downstream pathways in mesangial cells by which increased miR-192 expression may contribute to glomerulosclerosis, including TGF-β1 auto-induction and activation of Akt. Recently, Putta et al. [9] demonstrated that inhibition of miR-192 in streptozotocin-induced diabetic mice reduced proteinuria. Collectively, these studies indicate pleiotropic actions of miR-192-mediated Zeb1/2 repression that lead to important pathological changes in the context of diabetic nephropathy. miR-192 also plays an important role in sodium homoeostasis. Aldosterone-driven down-regulation of miR-192 in the distal nephron regulates sodium retention through loss of miR-192-mediated WNK lysine-deficient protein kinase 1 repression [10] .
miR-192 therefore has fundamental functional importance in key aspects of renal biology, and regulation of miR-192 expression has a significant impact on the nephron's response to a variety of physiological and pathological perturbations. However, comparatively little is known about the mechanisms regulating miR-192 expression. Locus-specific pri-miRs (primary miR transcripts) are transcribed by RNA polymerase II and are subject to similar transcription regulatory mechanisms as protein-encoding genes. pri-miRs undergo nuclear processing by the RNase III enzyme Drosha to one or more pre-miR hairpin precursors. Following cytoplasmic export, the RNase III enzyme Dicer processes pre-miRs to approximately 22 nucleotide miR duplexes from which the mature and bioactive miRs are derived [11] [12] [13] .
The purpose of the present study was to define the mechanisms by which miR-192 expression is regulated. Our results show transcriptional down-regulation by TGF-β1 of the pri-miR from which mature miR-192 is derived, together with co-repression of miR-194, originating from the same pri-miR. Further experiments identify a TGF-β1-responsive promoter element for pri-miR-194-2/192, and characterize regulation by the HNF (hepatocyte nuclear factor) and p53 transcription factor families.
Abbreviations used: EMSA, electrophoretic mobility-shift assay; HNF, hepatocyte nuclear factor; miR, microRNA; pri-miR, primary miR transcript; PTC, proximal tubular cell; RT-qPCR, reverse transcription quantitative PCR; SBS, Smad-binding site; SLC, solute carrier; siRNA, small interfering RNA; TGF, transforming growth factor; 3 -UTR; 3 -untranslated region. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email fraserdj@cf.ac.uk).
EXPERIMENTAL

General reagents
General reagents were purchased from Sigma-Aldrich and New England Biolabs, unless stated otherwise. SB-431542, a selective inhibitor of TGF-β type I activin receptor-like kinase (Alk5) receptors, was purchased from Sigma-Aldrich. Oligonucleotides were purchased from Invitrogen. Radioisotopes were purchased from PerkinElmer.
Cell culture
Primary human renal epithelial PTCs (proximal tubular cells) were isolated from normal tissue obtained from nephrectomy specimens as described previously [14] . The PTCs for the present study came from donor kidneys unsuitable for renal transplantation. There is a national arrangement whereby kidneys given for renal transplantation are offered for research purposes if they prove unsuitable for transplantation, provided consent for use in research was given at the time of donation. We have appropriate institutional approval for this work in place locally, and individual consent was in place before the kidney tissue was offered to us as a laboratory. Primary PTCs and the cell line HK-2 (PTCs immortalized by transduction with human papilloma virus-16 E6/E7 genes [15] ) were cultured as described previously [14] .
RT-qPCR (reverse transcription quantitative PCR)
RNA was prepared with TRIReagent (Ambion) according to the manufacturer's instructions. RNA from 20 different tissue types was purchased from Ambion. cDNA was generated using high-capacity reverse transcription (Applied Biosystems). qPCR was performed on a 7900-HT Fast Real-Time PCR System (Applied Biosystems). pri-miR-194-2/192 was quantified by Power SYBR ® Green PCR Master Mix (Applied Biosystems) with gene-specific primers (Supplementary Table S1 Table S2 ). mRNA expression was normalized to rRNA. The relative changes in gene expression were analysed by the 2 − CT method [16] .
Promoter constructs
A nested set of miR-194-2/192 promoter fragments ranging from 0.1 kb to 3 kb were created by PCR amplification using the primers listed (Supplementary Table S1 ). The sense strand primers incorporated a KpnI restriction endonuclease recognition sequence and the single antisense strand primer contained an XhoI recognition site. PCR amplification of promoter fragments was carried out from human gDNA (genomic DNA) using AccuPrime Taq DNA Polymerase High Fidelity (Invitrogen). PCR products were gel-purified with a QIAquick Gel Extraction Kit (Qiagen), double digested, cloned into pGL3 Basic reporter vector (Promega) and sequenced to ensure fidelity of amplification using the vector-specific primers RV3/GL2 (Supplementary Table S1 ).
Site-directed mutagenesis
Point mutations were created in the 0. Table S1 ).
Plasmid transient tranfection and luciferase reporter assay
Transient transfection of plasmids was carried out in 24-well plates using Lipofectamine TM LTX and PLUS Reagent (Invitrogen). Cells were growth arrested in serum-free medium 4 h prior to transfection with luciferase reporter constructs (pGL3 Basic) in combination with a Renilla luciferase control plasmid (pRL-SV40) (Promega) at a ratio of 9:1. At 24 h after transfection, the cells were lysed in passive lysis buffer (Promega). The firefly and Renilla luciferase activity was measured by a Dual-Luciferase Reporter Assay Kit (Promega), with a Fluostar Optima platereading luminometer (BMG Labtechnologies).
EMSA (electrophoretic mobility-shift assay)
Nuclear protein extraction was performed as described previously [17] . EMSAs were performed with DNA probes corresponding to the HNF and p53 transcription factor binding sites in the miR-194-2/192 promoter. The probes were created by annealing overlapping oligonucleotides (Supplementary Table S3 at http://www. BiochemJ.org/bj/443/bj4430407add.htm) with short 5 overhangs, radiolabelled with [α-32 P]dTTP using DNA Polymerase I, Large (Klenow) Fragment, and purified by illustra ProbeQuant G-50 Micro Columns (GE Healthcare). Binding reactions were performed with 2 μg of nuclear protein, 25 000 c.p.m. of radiolabelled probe in 10 mM Hepes, pH 8, 50 mM KCl, 10 % (v/v) glycerol, 0.2 mg/ml acetylated BSA, 1 mM DTT (dithiothreitol), 0.2 mM PMSF and 40 μg/ml poly(dI-dC), followed by electrophoresis through an 8 % non-denaturing polyacrylamide gel in 45 mM Tris-borate and 1 mM EDTA, pH 8. Gels were dried and complexes were detected by autoradiography. Specific HNF-DNA complexes were identified by supershift analysis using anti-HNF-1α, -HNF-1β and -HNF-4α antibodies (sc-10791, sc-22840 and sc-6556; Santa Cruz Biotechnology), and p53-DNA complexes were identified using anti-p53 antibody (2527; Cell Signaling Technology).
siRNA (small interfering RNA) transient transfection
Transient siRNA transfection was carried out in 12-well plates using Lipofectamine TM 2000 Reagent (Invitrogen). Cells were growth arrested in serum-free medium 4 h prior to transfection with siRNA at a final concentration of 100 nM. At 48 h after transfection, RNA was extracted and knockdown was analysed using RT-qPCR.
Statistical analysis
Statistical analyses were performed using GraphPad Prism v4 software. All data were expressed as means + − S.E.M. and assessed for significance by one-way ANOVA or unpaired Student's t test as appropriate. Results were considered statistically significant at P < 0.05. 
RESULTS
TGF-β1 down-regulates pri-miR-194-2/192, miR-192 and miR-194
We have previously shown down-regulation of mature miR-192 in PTCs by TGF-β1. miR-192 and miR-194 are highly expressed in the renal cortex when compared with the renal medulla [3] . The pre-miR sequence from which mature miR-192 is derived maps to chromosome 11q13. Reporter plasmids (P1-P10) containing genomic sequences between + 21 and − 2948 were evaluated using the Dual Luciferase Reporter Assay. (C) Effect of TGF-β1 on promoter activity: 10 ng/ml of TGF-β1 (closed bars), 10 ng/ml of TGF-β1 and 10 μM inhibitor of TGF-β1 type I activin receptor-like kinase (Alk) receptors (grey bars) and control (open bars). Genomic sequences were identified by their approximate size. Luciferase activity is expressed as the magnitude of normalized luciferase activity relative to the pGL3-Basic promoterless negative control vector. Error bars represent S.E.M. (n = 3); all genomic sequences were analysed by ANOVA, P < 0.05 (B), and control against TGF-β1 or TGF-β1 against TGF-β1 plus Alk receptor inhibitor were analysed by unpaired Student's t tests (C).
with ∼ 50 % decrease in the primary transcript and mature forms of the miRs in both cell types (Figure 1) . These results suggest repression of pri-miR-194-2/192 transcription by TGF-β1 in PTCs.
Characterization of pri-miR-194-2/192 promoter elements
Hino et al. [18] described chromosome 11 transcript AK092802, from which pri-miR-194-2/192 is derived. This sequence has since been annotated formally in GenBank ® as the two 'Homo sapiens pri-miR-194-2-192' tri-exonic splice-variant transcripts AB429223 and AB429224, in which the pri-miR-194-2/192 sequence resides in intron 2 ( Figure 2A ). The 5 terminal nucleotide of sequences AB429223 and AB429224, their transcription start site, coincided with that defined previously by 5 -rapid amplification of cDNA ends analysis for AK092802 [18] . The promoter driving transcription of the splice variants and miRs therefore lay directly upstream of this position. In silico analysis of the 5039 nucleotides comprising the first exon of AB429223/4 and 5 kb of upstream promoter sequence was performed using MatInspector as described previously [19] , and detected 1149 putative transcription factor binding sites (Supplementary Table  S4 at http://www.BiochemJ.org/bj/443/bj4430407add.htm).
We then used a heterologous reporter gene approach to identify key promoter elements regulating the transcription of pri-miR-194-2/192, as we have described previously [20] . Reporter vectors P1-P10 were generated, containing a nested series of genomic DNA sequence inserts spanning nucleotide positions + 21 to − 2948, where position + 1 represented the AB429223/4 transcription start site. The ability of these inserts to drive transcription of the firefly luciferase open reading frame was then analysed using the Dual Luciferase Reporter assay.
Constitutive promoter activity was detected in construct P1, with an inserted sequence spanning nucleotide positions + 21 to − 130. Vector P2 ( + 21 to − 223) showed increased luciferase synthesis, but constructs P3-P10 (P3, + 21 to − 330; P10, + 21 to − 2948) showed no further increase in constitutive promoter activity ( Figure 2B ). Our results therefore highlighted one region within the genomic DNA insert in the P1 reporter construct, and another in the P2 vector, that contributed to maximal constitutive luciferase activity of the AB429223/4 proximal promoter. Sequence analysis of the P1 and P2 genomic inserts in silico scored multiple hits for one HNF-1-specific nucleotide motif in the P1-P10 inserts, and binding and stimulatory HNF-1 transcriptional activity at this site have been described previously [18] . Between nucleotide positions − 135 to − 161 in the P2-P10 inserts, a functional site for binding of transcription factor p53 has been described, which does not have a full consensus binding motif sequence [21] .
Subsequently, we investigated whether these promoter elements were TGF-β1-responsive. Incubation with 10 ng/ml TGF-β1 resulted in a decrease in promoter activity of the P1, P9 and P10 reporter plasmids. This effect was prevented in the presence of a selective inhibitor of TGF-β type I activin receptor-like kinase (Alk5) receptors, confirming that it was a direct effect of TGF-β1 ( Figure 2C ). These results therefore suggested that the element regulating transcriptional responsiveness to TGF-β1 resided in the genomic sequence insert in the P1 construct.
Binding at the AB429223/4 promoter of the transcriptional modulator Smad3, which is activated by TGF-β1, has been described previously [22] . The authors identified three putative murine SBSs (Smad-binding sites) in silico, and used chromatin immunoprecipitation to demonstrate Smad3 binding in response to TGF-β1 at SBS1 and SBS2. However, TGF-β1 did not upregulate this interaction, suggesting that it was not mediated by a direct change in Smad3 DNA binding at this locus [22] . Chung et al. [22] also presented results showing evolutionary sequence conservation of SBS2 between murine and human genomes. This site lies approximately 3.3 kb upstream of the mature sequence of human miR-192, approximately 1.1 kb upstream of the AB429223/4 transcription start site, and was present in our P10 vector that did not show an up-regulated response to TGF-β1 in luciferase analysis ( Figure 2B ).
Our in silico analyses at the UCSC Genome Browser identified SBS2 and also provided evidence of sequence conservation. However, the SBS2 sequence resides within the 3 -UTR of the human ATG2 autophagy-related 2 homologue A (Saccharomyces cerevisiae) gene NM_015104, located immediately upstream of AB429223/4. Similarly, the 3 -UTRs of mouse (NM_194348) and rat (NM_001109545) Atg2a orthologues span the SBS1 and SBS2 sequences described previously [22] . The evolutionary conservation of these SBSs can therefore be explained, at least in part, by their presence within a highly conserved expressed sequence.
The effect of TGF-β1 on HNF-1α, HNF-1β, HNF-4α and p53
In order to determine whether the TGF-β1-mediated repression of miR-192 and miR-194 expression was mediated through HNF and p53 transcription factors, we first examined their expression. Incubation with 10 ng/ml TGF-β1 decreased HNF expression, most notably HNF-1α and HNF-4α, with little effect on p53 (Figure 3) . The responses were maximal at 72 h in HK-2 cells and 48 h in primary PTCs, with a decrease of approximately 60 % in HNF-1α and 75 % in HNF-4α in both cell types (Figure 3) .
TGF-β1 may interfere with HNF DNA binding independent of HNF expression, through interaction of Smad and HNF proteins [23] . Therefore we also studied HNF binding to the pri-miR-194-2/192 promoter, and the response to TGF-β1. EMSAs with nuclear protein extracts and a probe consisting of the HNF-1-binding site (HNF1) present in the pri-miR-194-2/192 proximal promoter identified the formation of two distinct DNA-protein complexes (Figures 4A and 4B) . Incubation with 10 ng/ml TGF-β1 decreased complex formation ( Figure 4B ). Specificity of binding was confirmed using a mutant probe ( HNF1) containing changes to key residues of the HNF-1-binding site, which abolished complex formation ( Figures 4A and 4B ). Supershift analysis using specific antibodies to HNF-1α, HNF-1β and HNF-4α was used to determine the constituents of the DNA-protein complexes. The addition of HNF-1β antibody decreased the mobility of both complexes ( Figure 4C ) and, at an increased concentration, HNF-1α antibody depleted the lower complex ( Figure 4D ). HNF-4α antibody had no effect on mobility of either complex ( Figure 4C ).
EMSAs with nuclear protein extracts and a probe consisting of the p53-binding site (p53) present in the pri-miR-194-2/192 proximal promoter identified the formation of two distinct DNAprotein complexes ( Figure 5 ). However, incubation with 10 ng/ml TGF-β1 did not affect the complex formation ( Figure 5B ). Specificity of binding was confirmed by using a mutant probe ( p53) as described above ( Figure 5 ).
Mutation of pri-miR-194-2/192 promoter HNF-1 and p53 binding sites
To test the role of HNF-1 in TGF-β1-mediated repression of miR-192 and miR-194, we created reporter constructs with mutations to key residues in the HNF-1-and p53-binding sites, and evaluated them using the Dual Luciferase Reporter Assay as described above. Initially we made a four-point mutation to the HNF-1-binding site ( HNF1) in the P1 reporter plasmid that does not contain the p53-binding site, which resulted in a 90 % decrease in promoter activity ( Figure 6 ). Next we mutated the HNF-1 ( HNF1) or the p53-binding site ( p53) individually or in combination in the P2 reporter plasmid, which contains both sites ( Figure 6 ). Both mutations, either individually or in combination, resulted in a 90 % decrease in promoter activity (Figure 6 ), suggesting that they are both required for efficient transcription.
siRNA knockdown of HNF-1 mRNAs
We used an siRNA approach to target HNF expression, to determine whether direct repression of HNFs would reproduce the effect of TGF-β1, and lead to down-regulation of miR-192 and miR-194. siRNA targeting HNF-1α and HNF-1β produced effective mRNA knockdown of approximately 75 % (Figures 7A  and 7B ), resulting in a statistically significant decrease in the expression of miR-192 and miR-194 of 40 % and 50 % respectively ( Figures 7C and 7D ).
Tissue expression of miR-192, miR-194, HNF-1α, HNF-1β, HNF-4α and p53
The results discussed above suggest a co-ordinated transcriptional regulation of miR-192 and miR-194 by HNF and p53 transcription factors. We therefore analysed the tissue expression patterns of these miRs together with the transcription factors HNF-1α, HNF-1β, HNF-4α and p53. miR-192 and miR-194 demonstrated similar expression patterns, highly and selectively expressed in kidney, small intestine, colon and liver (Figures 8A Figures 8C and 8E) , and HNF-1β, although more widely distributed, was also highly expressed in the kidney ( Figure 8D ). In contrast, the expression of p53 was ubiquitous across the 20 different tissue types analysed ( Figure 8F ).
DISCUSSION
Further to our recent study associating down-regulation of miR-192 with fibrosis in diabetic nephropathy [4] , in the present study we set out to analyse the regulation of miR-192 in PTCs. TGF-β1 down-regulated expression of miR-192 and its cluster partner miR-194. Analysis of the shared promoter for miR-192 and -194 showed constitutive promoter activity that was dependent on HNF and p53 promoter sequence motifs, and was decreased by TGF-β1 through an Alk5-dependent mechanism. miR and HNF expression was restricted to a defined subset of tissues, including kidney, small intestine, colon and liver. TGF-β1 treatment decreased HNF binding to the miR-194-2/194 promoter, whereas knockdown of HNF-1 inhibited mature miR-192 and miR-194 expression. These results identify co-ordinated regulation of miR-192 and miR-194 in PTCs, with binding of HNF and p53 transcription factors necessary for activation of transcription, and TGF-β1-mediated repression of miR-192 and miR-194 expression through decreased HNF binding to its cognate promoter element.
In proximal tubular cells, expression of E-box repressors, including Zeb1, Zeb2, Snail1 and Snail2, is associated with a loss of epithelial characteristics, and acquisition of a mesenchymal phenotype. Zeb1 and Zeb2 are targets of miR-192, and hence loss of miR-192 expression in proximal tubular cells facilitates epithelial-mesenchymal transition [4, 5] . miR-192 has also recently been identified as a downstream effector of p53, responsible for repression of Zeb1/Zeb2-directed epithelialmesenchymal transition in conjunction with the miR-200 family [21] . In mesangial cells, repression of Zeb1 and Zeb2 by miR-192 facilitates collagen synthesis and promotes glomerulosclerosis [6] . A recent study also showed that WNK1 is a miR-192 target, such that in the distal nephron, aldosterone-driven miR-192 suppression is an important mediator of sodium retention [10] .
Taken together, these results suggest that precise regulation of miR-192 expression has important consequences throughout the nephron. In the present study, we have identified key mechanisms by which miR-192 expression is regulated in PTCs. Our results show that the pri-miR-194-2/192 transcript is controlled by p53 and HNF transcription factor binding, leading to co-expression of miR-192 with miR-194. miR-194 is linked to intestinal epithelial differentiation [18] , but its potential roles in renal physiology and pathology are currently undetermined. Previous studies highlight other instances of co-ordinated expression of miRs transcribed from single contiguous polycistronic primary transcripts [24] . The best studied to date, the miR-17-92 cluster, yields six mature miRs, exhibiting functional pleiotropy during tumorigenesis dependent on cell type and context [25] . The potential co-ordinated function of miR-192 and miR-194 in renal epithelial cells may be an interesting area for future research.
Our results of the present study identify HNFs as key regulators of miR-192 and miR-194 transcription, and are suggestive that miR-192 and miR-194 may represent important effectors of HNF function in the kidney. HNFs play fundamental roles in development and tissue homoeostasis [26, 27] . In the kidney, HNF-1α and HNF-4α are expressed in PTCs, whereas HNF-1β is expressed in tubular epithelial cells in all segments of the nephron and collecting ducts [26, 27] . Mutations in HNF-1α, HNF-1β and HNF-4α are responsible for monogenic types of maturity-onset diabetes of the young, and renal cysts and diabetes syndrome [26, 28] . Knockout mice for HNF-1α have morphologically normal kidneys, but develop glucosuria and phosphaturia owing to reduced expression of the sodium/glucose transporter and the sodium/phosphate transporters NPT1 {SLC17A1 [solute carrier family 17 (sodium phosphate), member 1]} and NPT2 (SLC34A1) [26] .
Although several studies show decreased miR-192 expression in various renal pathologies and models [4, 5, [29] [30] [31] , several others show increases in miR-192 [6, 22, [32] [33] [34] [35] . In PTCs, decreased miR-192 facilitates expression of its targets Zeb1 and Zeb2, and hence loss of the key epithelial marker E-cadherin [4] . In mesangial cells, in contrast, TGF-β1 increases miR-192 expression, and the resultant repression of Zeb1 and Zeb2 enables expression of pro-fibrotic genes, including collagens, and mesangial cell hypertrophy [6] [7] [8] . This suggests that there may be lineagespecific variation in control of miR-192 expression, and that elucidating the mechanisms that control miR-192 expression in mesangial cells may highlight important differences from PTCs. A more complete understanding of the role of miR-192 in renal physiology and disease may also require future studies examining expression in different nephron segments in vivo, and consideration of the full range of miR-192 targets, which is known to include regulators of circadian rhythm [36] and cell cycle [21, 37, 38] .
In the present study, TGF-β1 decreased HNF-pri-miR-194-2/192 promoter complex formation without altering the expression of HNF-1β, the predominant HNF isoform in PTCs and found by us to be the major component of HNF-DNA complexes. TGF-β1 down-regulated HNF-1α and HNF-4α, which act in concert with HNF-1β to form DNA complexes. Cell phenotype-and context-dependent transcriptional responses to TGF-β1 are well recognized, and have recently been linked to combinatorial interactions of Smad and HNF proteins [39] . TGF-β1 is also known to regulate HNF DNA binding independent of HNF expression, via binding of phosphorylated Smad proteins to HNFs downstream of active TGF-β1 receptor complexes [23] .
Our results from the present study also indicate that p53 binding is important in pri-miR-194-2/192 transcription in proximal tubular cells. p53 has recently been identified as a key transcriptional regulator of miR-192, miR-194 and miR-215 in plasma cells, and additionally these miRs are important downstream effectors of p53 function [21] . Validated targets of these miRs include the G 1 /G 2 checkpoint proteins BCL2, CDC7 (cell division cycle 7), MAD2L1 (MAD2 mitotic arrest deficient-like 1) and CUL5 (cullin 5) [37] , and also MDM2 (murine double minute 2), a negative regulator of p53 [21] . Expression of miR-192, miR-194 and miR-215 therefore prevents p53 degradation, increasing activity of p53 and its other downstream targets, including CDKNA1, p21 and p27 [21] . Ultimately the expression of miR-192, miR-194 and miR-215 may trigger G 1 and G 2 cell cycle arrest in a p53-dependent manner [21, 37, 38, [40] [41] [42] . p53 expression is linked to terminal differentiation of cells in the kidney and elsewhere [43, 44] . We speculate that one mechanism by which p53 acts to control proliferation and maintain differentiation in renal epithelial cells is via miR-192 and miR-194.
In summary, in the present paper we have identified coordinated regulation of miR-192 and miR-194 in PTCs by HNF and p53 transcription factors. These results may have important implications for miR-192 regulation in the contexts of renal fibrosis and in homoeostatic responses related to sodium handling. The mRNA targets and downstream effects of miR-194, coexpressed from the miR-192 locus, are an important area for future study. 
